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ABSTRACT
4′-Acylated thymidines represent a new class of DNA
chain terminators, since they have been shown to act
as post-incorporation chain-terminating nucleotides
despite the presence of a free 3′-hydroxyl group. Here,
we describe the action of the 4′-acetyl- (MeTTP) and
4′-propanoylthymidine 5′-triphosphate (EtTTP) on
HIV-1 reverse transcriptase in RNA- and DNA-depend-
ent DNA synthesis and on DNA synthesis catalyzed by
the cellular DNA polymerases α, β, δ and ε. MeTTP
exhibits a high selectivity towards HIV-1 reverse
transcriptase. By the use of the bulkier propanoyl
group as the 4′-substituent of the nucleoside 5′-tri-
phosphate, selectivity towards HIV-1 reverse trans-
criptase could be increased without affecting sub-
strate efficiency. Thus, 4′-modifications may serve as
a tool to increase selectivity towards HIV-1 reverse
transcriptase.
INTRODUCTION
DNA chain-terminating nucleoside analogs have found wide
application in DNA sequencing techniques and antiviral chemo-
therapy. A common feature of chain-terminating nucleotides used
in DNA sequencing procedures is lack of a 3′-hydroxyl function-
ality on the 2′-deoxyribose, such as in 2′,3′-dideoxyribonucleo-
tides or in 7-deaza-2′,3′-deoxyguanosine (1,2). In antiviral
chemotherapy to combat human immunodeficiency virus (HIV)
infection, inhibition of reverse transcription catalyzed by HIV-1
reverse transcriptase (RT) is the mode of action of clinically
approved nucleoside drugs. Chain termination is believed to be
the primary mechanism by which the corresponding antiviral
nucleoside analog 5′-triphosphates exert their anti-HIV activities.
A common structural feature of these nucleoside analogs is either
lack of a 3′-hydroxyl functionality as found in the 2′,3′-dideoxyri-
bonucleosides [like ddI, ddC or 2′,3′-didehydro-2′,3′-dideoxyri-
bonucleosides (e.g. D4T)] or its substitution by another function-
ality [like 3′-azidothymidine (AZT)] (3–10). Nucleoside 5′-tri-
phosphates with other modifications at the 2′-deoxyribose moiety
as well as a free 3′-hydroxyl group are known to be substrates for
DNA polymerases (DNA pols) and also RTs. Incorporation of
these nucleotide analogs, which include 4′-azidothymidine
5′-triphosphate (11), arabinofuranosyl nucleotides [like araC
(cytarabine) and F-ara-A (fludarabine)] (12,13) and 2′,2′-difluo-
rodeoxycytidine (gemcitabine) (14), do not lead to DNA chain
termination, whereas inhibitors lacking the 3′-hydroxyl function-
ality do. Inhibition of reverse transcription is believed to proceed
via a pseudo-chain-termination mechanism (11–14). The aim in
the design of new antiviral nucleosides is to develop tools which
lead to high selectivity towards the targeted enzyme.
Recently, we have shown that the 4′-acylated thymidines
4′-acetylthymidine 5′-triphosphate (MeTTP) and 4′-propanoyl-
thymidine 5′-triphosphate (EtTTP) (for structures see Fig. 1) act
as post-incorporation chain-terminating nucleotides on several
DNA pols of the DNA pol I family and RTs despite the presence
of a free 3′-hydroxyl group in the deoxyribose (15,16).
They represent a new class of DNA chain-terminating nucleo-
tides even though they have a free 3′-hydroxyl group. We have
found that the 4′-modification is an excellent tool to increase
selectivity towards HIV-1 RT. In the present study, we describe
the action of the 4′-acylated thymidines MeTTP and EtTTP on
HIV-1 RT in RNA- and DNA-dependent DNA synthesis and on
DNA synthesis catalyzed by the cellular DNA pols α, β, δ and ε.
Both thymidine analogs were used as substrates by HIV-1 RT
with similar efficiency. DNA pol α was able to use the
methylketone MeTTP as a substrate, whereas the ethylketone
EtTTP was not a substrate for DNA pol α. None of the other
cellular DNA pols present in the nucleus (DNA pol β, δ and ε)
were able to use the 4′-modified thymidine analogs. Thus,
selectivity towards HIV-1 RT could be enlarged by changing the
size of the 4′-substituent without affecting the substrate efficiency
of the nucleotide for the lentiviral enzyme. These observations
may be exploited to develop strategies for the design of new
nucleosidic antiviral chemotherapeutics with higher selectivity.
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Figure 1. Structures of the 4′-acylated thymidine 5′-triphosphates MeTTP and
EtTTP.
MATERIALS AND METHODS
Materials
MeTTP and EtTTP were synthesized according to the procedure
described previously (15,17). Standard nucleotides and Escheri-
chia coli 16S and 23S rRNA were purchased from Boehringer
Mannheim. DNA oligonucleotides were prepared with a solid
phase DNA synthesizer (Applied Biosystems) from β-cyano-
ethyl-protected phosphoramidites, purified by the ‘trityl-on’
procedure, deprotected and purified by HPLC and PAGE. DNA
primers were labeled at the 5′-end with [γ-32P]ATP (5000
Ci/mmol; Amersham) and T4 polynucleotide kinase (New
England Biolabs) (2). Human DNA pol β was purchased from
Chimerx. HIV-1 RT was purified as described (18). Calf thymus
DNA pols α, δ and ε were purified according to published
procedures (19–21). Proliferating cell nuclear antigen (PCNA)
was overexpressed and purified as described (22). One unit of
DNA pol activity corresponds to incorporation of 1 nmol
2′-deoxyribonucleoside monophosphate into acid-precipitable
material in 60 min at 37C.
Enzyme reaction buffers
Buffer A: 20 mM Tris–HCl, pH 7.5, 6 mM MgCl2, 40 mM KCl,
0.5 mM DTT. Buffer B: 20 mM K2HPO4/KH2PO4, pH 7.2,
10 mM MgCl2, 0.5 mM DTT, 1.25 mg/ml BSA. Buffer C: 50 mM
Tris–HCl, pH 8.7, 10 mM MgCl2, 10 mM KCl, 1 mM DTT.
Buffer D: 50 mM Tris–HCl, pH 6.5, 5 mM MgCl2, 0.5 mM DTT,
1.25 mg/ml BSA.
DNA primer extension on 16S rRNA template
The 5′-end-labeled 20 base oligonucleotide primer was annealed
to its complementary site on E.coli 16S rRNA (positions 116–135
using the deoxyribonucleotide numbering system of 23) by
heating the DNA primer and a mixture of 16S and 23S rRNA to
80C for 5 min and subsequent cooling to 25C within 1 h.
(5′) d(32P-GCAGTTTCCCAGACATTACT)
(3′) r(...CGUCAAAGGGUCUGUAAUGAGUGGGCAGGCGG...)
| |
20 27
Each DNA primer extension reaction mixture (10 µl) con-
tained, dissolved in buffer A, 73 fmol labeled 20 base DNA
primer, 0.5 µg E.coli 16S/23S rRNA mixture and 10 µM each
dATP, dGTP and dCTP and various concentrations of TTP,
MeTTP or EtTTP as indicated in the figure legends. The reactions
were initiated by addition of 0.3 U HIV-1 RT and incubated for
15 min at 37C and analyzed in an 11% polyacrylamide
denaturating sequencing gel (National Diagnostics). After elec-
trophoresis the gel was transferred to filter paper (Whatmann
3MM) and dried at 80C. The radioactivity in the DNA bands
was quantified using a PhosphorImager (Molecular Dynamics).
The relative velocities of incorporation of MeTTP and EtTTP
were determined by dividing the radioactivity in the first T site
(position 27) by radioactivity of the band 1 nt shorter (position
26), as previously described (8,9,24). The Km and Vmax values
were then calculated from the Michaelis–Menten equation.
DNA primer extension on a DNA template
The 5′-end-labeled 20 base oligonucleotide primer was annealed
to its complementary site on a 40 base oligonucleotide as
described above.
(5′) d(32P-GTGGTGCGAATTCTGTGGAT
(3′)    d(CACCACGCTTAAGACACCTAGTCGTTCCTACTTGCTGGCT)
| |
20 30
DNA primer extension reactions with HIV-1 RT contained, in a
final volume of 10 µl in buffer A, 73 fmol labeled 20 base DNA
primer, 230 fmol 40 base DNA template and 10 µM each dATP,
dGTP and dCTP, various concentrations of TTP, MeTTP or EtTTP
as indicated in the figure legends and 0.05 U HIV-1 RT. Incubation
was performed for 15 min at 37C and analyzed and quantified as
described above. DNA primer extension reactions with DNA pols
α and β were performed in buffers B and C respectively and 0.1 U
enzyme was used. When DNA pol δ was used to perform DNA
primer extension each reaction mixture (20 µl) contained, in buffer
D, 36 fmol labeled 20 base DNA primer, 54 fmol 40 base DNA
template, 90 ng PCNA and 20 µM each dATP, dGTP and dCTP,
various concentrations of TTP, MeTTP or EtTTP as indicated in
the figure legends and 0.01 U DNA pol δ. Incubation was
performed for 15 min at 37C and the products were analyzed and
quantified as described above. When DNA pol ε was used to
catalyze DNA synthesis the reaction mixtures (20 µl) contained, in
buffer D, 36 fmol labeled 20 base DNA primer, 54 fmol 40 base
DNA template and 30 µM each dATP, dGTP and dCTP and
various concentrations of TTP, MeTTP or EtTTP as indicated in
the figure legends. The reactions were initiated by addition of 0.4 U
DNA pol ε, incubated for 15 min at 37C and the products
analyzed and quantified as described above.
RESULTS
DNA primer extension on RNA template catalyzed by
HIV-1 RT
The action of the 4′-acylated thymidine 5′-triphosphates MeTTP
and EtTTP (for structures see Fig. 1) on reverse transcription was
studied using E.coli 16S rRNA (9) as template to which a
5′-32P-labeled 20 base DNA primer was annealed. As shown in
Figure 2, in the presence of dATP, dGTP and dCTP and in the
absence of TTP, HIV-1 RT extended the primer six deoxyribonu-
cleotides to form a main reaction product with a length of 26 nt
(Fig. 2, lane 1).
When increasing concentrations of either MeTTP or EtTTP
(1–100 µM) were added to the reaction mixture a decrease in the
amount of the 26 base product and an increase in the 27 base
product was observed (Fig. 2, lanes 2–15). This indicated that
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Figure 2. Incorporation of MeTTP and EtTTP into DNA by HIV-1 RT using
rRNA template. The numbers on the left side of the figure indicate the length
of oligonucleotide synthesized in primer extension. Lane 1, HIV-1 RT
incubated with 10 µM each dATP, dCTP and dGTP and 32P-labeled 20 base
DNA primer annealed to 16S rRNA; lanes 2–8, as lane 1 but with 1, 6, 10, 15,
20, 50 and 100 µM MeTTP respectively; lanes 9–15, as lane 1 but with 1, 6, 10,
15, 20, 50 and 100 µM EtTTP respectively; lane 16, control reaction, as lane 1 but
with 10 µM TTP.
HIV-1 RT was able to use both MeTTP and EtTTP as substrates
for incorporation into the first T site in RNA-dependent DNA
synthesis. Formation of the 27 base product was clearly due to
incorporation of the thymidine analogs MeTTP and EtTTP into
the nascent DNA strand, since no pausing at position 27 was
observed when the reaction was performed in the presence of all
four natural dNTPs (Fig 2, lane 16). Most of the cDNA products
in the reaction shown in Figure 2, lane 16 ran higher on the gel
and are therefore not visible. There were no indications that
further DNA strand elongation occurs after incorporation of both
4′-modified thymidine analogs, despite the presence of a free
3′-hydroxyl group at the primer terminus. Both analogs acted as
post-incorporation DNA chain terminators. The radioactivity in
sites 26 and 27 was quantitated and the incorporation kinetics (Km
and Vmax) were determined as described in Materials and
Methods. As shown in Table 1, the Km value for incorporation of
MeTTP into the first T site (position 27) by HIV-1 RT was 2- to
3-fold less than that for incorporation of EtTTP, indicating that
HIV-1 RT has a higher affinity for MeTTP. Interestingly, the
substrate efficiency (Vmax/Km) (8,9,24) for MeTTP was the same
as for the bulkier EtTTP.
DNA primer extension on DNA template catalyzed by
HIV-1 RT
Recently we showed that DNA-directed incorporation of MeTTP
by HIV-1 RT can result in a slower further elongation at the
primer 3′-terminus when a high enzyme:DNA substrate ratio was
employed (15,16). However, to quantitate nucleotide insertion
kinetics the enzyme has to be saturated with its DNA substrate
and therefore low enzyme:DNA substrate ratios have to be
Figure 3. Incorporation of MeTTP and EtTTP into DNA by HIV-1 RT using
DNA template. The numbers on the left side of the figure indicate the length of
oligonucleotide synthesized in primer extension. LM, line marker. Lane 1,
HIV-1 RT incubated with 10 µM each dATP, dCTP and dGTP and 32P-labeled
20 base DNA primer annealed to 40 base DNA template; lanes 2–10, as lane
1 but with 1, 6, 10, 15, 20, 50, 100, 150 and 200 µM MeTTP respectively; lanes
11–19, as lane 1 but with 1, 6, 10, 15, 20, 50, 100, 150 and 200 µM EtTTP
respectively; lane 20, control reaction, as lane 1 but with 10 µM TTP.
employed (8–10,24). Under these conditions, MeTTP acted as a
post-incorporation DNA chain terminator in DNA-dependent
DNA synthesis catalyzed by HIV-1 RT (Fig. 3). When the DNA
20 base primer/40 base template (for sequences see Materials and
Methods) were incubated with HIV-1 RT in the presence of dATP,
dGTP and dCTP without TTP, the 20 base primer was extended
by 9 nt to form a major stop site (position 29), one position before
the first T site (Fig. 3, lane 1).
The formation of longer reaction products indicated that some
non-complementary dNTP molecules were incorporated into the
first T site and subsequently the DNA primer strand was further
elongated. This misincorporation tendency of HIV-1 RT confirms
its known error-prone properties (25–28). When HIV-1 RT
catalyzed primer extension in the presence of increasing con-
centrations of the 4′-acylated thymidine analog MeTTP or EtTTP
(1–200 µM), increasing incorporation was observed by accu-
mulation of 30 base reaction products (Fig. 3, lanes 2–19). Again,
with the use of TTP instead of MeTTP or EtTTP (Fig. 3, lane 20)
it could be confirmed that formation of the 30 base product can
be ascribed to incorporation of the thymidine analogs. The kinetic
parameters were determined as described above and are listed in
Table 1. The Km value for MeTTP incorporation with the DNA
template is similar to the Km value with the RNA template. For
EtTTP, we found the Km value and substrate efficiency in this
reaction to be of the same order of magnitude as for MeTTP. The
Km value for incorporation of EtTTP in the DNA-dependent
reaction turned out to be 3-fold less than found in the reverse
transcription reaction.
Table 1. Kinetic parameters of MeTTP and EtTTP incorporation into DNA
Enzyme Analog 16S rRNA template 40 base DNA template
Km (µM) Vmax Vmax/Km (per µM) Km (µM) Vmax Vmax/Km (per µM)
HIV-1 RT MeTTP 15 2.9 0.19 10 1.6 0.16
EtTTP 42 5.6 0.13 12 2.4 0.20
DNA pol α MeTTP n.a. n.a. n.a. 338 0.72 0.002
n.a., not applicable, since DNA pol α does not copy RNA templates.
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Figure 4. Action of MeTTP and EtTTP on DNA pol α. The numbers on the left
side of the figure indicate the length of oligonucleotide synthesized in primer
extension. LM, line marker. Lane 1, DNA pol α incubated with 10 µM each
dATP, dCTP and dGTP and 32P-labeled 20 base DNA primer annealed to 40
base DNA template; lanes 2–5, as lane 1 but with 50, 100, 150 and 200 µM
MeTTP respectively; lanes 6–9, as lane 1 but with 50, 100, 150 and 200 µM
EtTTP respectively; lane 10, control reaction, as lane 1 but with 10 µM TTP.
DNA primer extension catalyzed by cellular DNA pols
To evaluate the action of the 4′-acylated thymidines MeTTP and
EtTTP on cellular DNA pols we used the DNA primer/template
complex described above. When DNA pol α was used to perform
primer elongation in the presence of dATP, dGTP and dCTP,
formation of a 29 base DNA product as major reaction product
was observed (Fig. 4, lane 1).
Only trace amounts of misincorporation were observed in this
case. In the presence of increasing concentrations of MeTTP
(50–200 µM) DNA pol α incorporated this analog into the
nascent DNA strand (Fig. 4, lanes 2–5). The kinetic parameters
were obtained as described above and are listed in Table 1. The
Km value for incorporation of MeTTP by DNA pol α is ∼30-fold
greater than that obtained with HIV-1 RT. The substrate efficiency
of DNA pol α for MeTTP is ∼100-fold lower than that for HIV-1
RT. Interestingly, no indication of post-incorporation chain
elongation could be obtained. Therefore, MeTTP acts as a chain
terminator for DNA pol α as well, in spite of the free 3′-hydroxyl
group. If primer elongation by DNA pol α was performed in the
presence of the moderately bulkier EtTTP, no incorporation of the
thymidine analog could be detected (Fig. 4, lanes 6–9). Thus, an
increase in the bulk of the 4′-acyl modification of the analog by
only one CH2 moiety ensures that this analog is no longer a
substrate for DNA pol α. If, however, the three DNA pols β, δ and
ε present in the nucleus were tested with the same concentrations
of MeTTP and EtTTP and under optimal conditions for each
enzyme, neither of the thymidine analogs was incorporated into
the growing DNA strand by any of these other three cellular DNA
pols (Fig. 5).
DISCUSSION
In spite of the fact that the 4′-acylated thymidines MeTTP and
EtTTP bear a free 3′-hydroxyl group, this study indicates that
their incorporation into DNA blocks further DNA chain elonga-
tion. DNA pols are thought to catalyze DNA polymerization by
sequential conformational changes in the enzyme structure
(29–31). HIV-1 RT is thought to undergo a conformational
change after binding the nucleoside 5′-triphosphate, which
positions the nucleotide for phosphodiester bond formation (31).
Therefore, the binding affinity of the nucleotide substrate at the
active site in the RT is crucial for incorporation. The Km value
represents a parameter for the binding affinity of the nucleotide
at the active site (24). From the Km values the differences in the
free binding energies of MeTTP and EtTTP can be calculated
(24). It turned out that the free binding energy of MeTTP for
HIV-1 RT in reverse transcription is ∼0.6 kcal/mol higher than for
EtTTP. This may be due to the bulkier 4′-substituent, which may
interfere with the enzyme or fix the sugar pucker conformation
unfavorably for binding. However, the Km values for DNA-
directed DNA synthesis with MeTTP and EtTTP are about the
same. The substrate efficiency of both substrates was found to be
about the same for both reactions. These studies revealed that an
increase in the size of the 4′-substituent by one methylene moiety
did not have a significant effect on nucleotide binding and
incorporation. In contrast, as shown recently (15,16), HIV-1 RT
Figure 5. Action of MeTTP and EtTTP on DNA pols β, δ and ε. (Left) LM, line marker. Lane 1, DNA pol β incubated with 10 µM each dATP, dCTP and dGTP and
32P-labeled 20 base DNA primer annealed to 40 base DNA template; lanes 2–5, as lane 1 but with 50, 100, 150 and 200 µM MeTTP respectively; lanes 6–9, as lane
1 but with 50, 100, 150 and 200 µM EtTTP respectively; lane 10, control reaction, as lane 1 but with 10 µM TTP. (Center) LM, line marker. Lane 1, DNA pol δ incubated
with 20 µM each dATP, dCTP and dGTP, PCNA and 32P-labeled 20 base DNA primer annealed to 40 base DNA template; lanes 2–4, as lane 1 but with 100, 150 and
200 µM MeTTP respectively; lanes 5–7, as lane 1 but with 100, 150 and 200 µM EtTTP respectively; lane 8, control reaction, as lane 1 but with 10 µM TTP.
(Right) As in the left panel but with DNA pol ε.
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is able to promote chain elongation after incorporation of the
methylketone MeTTP when high enzyme quantities are used. The
ethylketone EtTTP acts as a chain-terminating nucleotide upon
incorporation. Thus, the size of the 4′-modification is less crucial
for incorporation of the nucleotide by HIV-1 RT than for
post-incorporation DNA elongation.
The Km values obtained for incorporation of MeTTP and
EtTTP are about the same and up to 50-fold greater than reported
for TTP or antiviral nucleoside 5′-triphosphates such as ddTTP,
AZTTP and D4TTP elucidated in similar assays (8,9). It should
be emphasized that the kinetic values for incorporation of normal
nucleotides is dependent on the sequence under evaluation (31).
Therefore, a direct comparison of the kinetic values should be
done with caution. In treatment of antiviral diseases, the
nucleosidic drugs are applied as nucleosides and have to be
transformed into the corresponding 5′-triphosphates by cellular
kinases to be effective drugs. For further evaluation, the action of
4′-acylated thymidines on cellular kinases has to be studied.
As mentioned, selectivity towards a targeted enzyme is
desirable in the design of new therapeutic agents. Therefore, we
evaluated the action of MeTTP and EtTTP on four DNA pols (for
reviews see 32–34) which are essential in cellular DNA
replication (DNA pols α, δ and ε), in DNA repair processes (DNA
pols β, δ and ε), in repair recombination (DNA pol ε; 35) and in
V(D)J recombination (DNA pol δ; 36). It turned out that the
4′-acylated thymidine analogs were very poor substrates for all
cellular DNA pols tested. Only DNA pol α was able to
incorporate MeTTP, at ∼100-fold less substrate efficiency than
that obtained for HIV-1 RT. The bulkier EtTTP was not
incorporated by DNA pol α. DNA pols β, δ and ε incorporated
neither MeTTP nor EtTTP. Thus, an increase in size of the
4′-modification ensures that the thymidine analog EtTTP is not
a substrate for incorporation by any cellular nuclear DNA pol.
Since this structural modification does not change the sugar
pucker conformation (17), the different reactivity of EtTTP to
MeTTP can be ascribed to the increased bulk of the 4′-substituent.
Our studies demonstrate that the 4′-acylated thymidine analogs
MeTTP and EtTTP are preferentially incorporated into DNA by
HIV-1 RT. To assess the influence of the 4′-acyl modification on
DNA synthesis catalyzed by HIV-1 RT and cellular DNA pols the
size of the sugar pucker substituent was increased. Enlargement
of the 4′-methylketone MeTTP by one methylene moiety to the
4′-ethylketone EtTTP resulted in rejection of the thymidine
analog as a substrate for cellular nuclear DNA pols, without
reducing its substrate efficiency for HIV-1 RT in comparison with
MeTTP. Thus, the 4′-modification may serve as a tool to increase
selectivity towards the lentiviral enzyme. These observations
make 4′-modified nucleotides very interesting in the search for
new nucleosidic drugs. Additionally, it would be quite significant
if this strategy could also be applied to other positions of the sugar
residue of nucleotides. Investigations along these lines are in
progress.
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